SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-21-013184
Filing Date
2021-02-08
Accepted
2021-02-05 20:34:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tm215631d1_sc13ga.htm SC 13G/A 49792
  Complete submission text file 0001104659-21-013184.txt   51168
Mailing Address 712 FIFTH AVENUE 49TH FLOOR NEW YORK NY 10019
Business Address
RAPP MICHAEL (Filed by) CIK: 0001405685 (see all company filings)

Type: SC 13G/A

Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Subject) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88971 | Film No.: 21598267
SIC: 2834 Pharmaceutical Preparations